Study of Epratuzumab in Systemic Lupus Erythematosus

NCT00383513 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma